The objective of the study was to determine possible differences in percept
ion of quality of life (QoL) between patients with metastatic breast or pro
state cancer, their partners, and the treating physician. Patients with met
astatic breast cancer (n = 71), and metastatic prostate cancer (n = 29), a
partner, and the physician each completed the same QoL questionnaire indica
ting how they perceived the patient's QoL. The European organization for re
search and treatment of cancer (EORTC) QLQ-C30 questionnaire was used to as
sess patients with breast cancer and the modified prostate cancer specific
quality of life instrument (PROSQOLI) for patients with prostate cancer. Th
ere was reasonable agreement in mean scores between patients, and physician
s or partners, for many domains of QoL; however, there was substantial disc
ordance between scores when considering individual patients. For patients w
ith metastatic breast cancer, physicians systematically underestimated over
all QoL (p = 0.0002). social functioning (p = 0.001). and role functioning
(p = 0.008), while partners showed better agreement. With prostate cancer p
hysicians tended to underestimate pain, while mean scores for spouses were
more concordant. There is substantial variability between ratings of QoL by
physicians or partners, as compared to patient ratings. Medical decisions
should be based on information about QoL provided by patients using validat
ed methods.